Eli Lilly & Co. (NYSE:LLY)
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
549549
(91.39)
Submitted: 1/4/2007 11:57:53 AM :
Start Price:
$40.37
LLY Score:
+2.49
big farma a bit undervalued, look for it to outpace the S&P this year
Recs
dymwit
(26.01)
Submitted: 1/3/2007 12:47:34 PM :
Start Price:
$40.53
LLY Score:
+3.45
should rebound
Recs
OldNickel
(98.26)
Submitted: 12/28/2006 11:28:18 PM :
Start Price:
$39.82
LLY Score:
-4.53
The Democrats are coming! The Democrats are coming!
Recs
tcampbellla
(< 20)
Submitted: 12/19/2006 6:38:50 PM :
Start Price:
$40.41
LLY Score:
-3.19
Increasing negative news. This company is on the way out.
Recs
borgeron
(< 20)
Submitted: 12/8/2006 8:26:28 AM :
Start Price:
$41.41
LLY Score:
-0.10
Drug in pipeline will drive earnings
Recs
slowplay68
(< 20)
Submitted: 12/7/2006 4:44:03 PM :
Start Price:
$41.41
LLY Score:
-0.10
an old classic
Recs
StroudG
(86.80)
Submitted: 12/7/2006 4:21:45 PM :
Start Price:
$41.41
LLY Score:
-0.10
The research pipeline is strong. CEO knows the business, company and industry.
Recs
lakers1000
(95.81)
Submitted: 12/5/2006 8:42:09 PM :
Start Price:
$41.90
LLY Score:
+1.08
Watch out (BOOOOOOM)
Recs
Richzski
(33.02)
Submitted: 11/16/2006 4:22:19 PM :
Start Price:
$42.00
LLY Score:
-2.31
Even with Dem control
Recs
eicherkops
(< 20)
Submitted: 11/7/2006 10:26:25 AM :
Start Price:
$43.74
LLY Score:
-7.02
Heavily invested in diabetes research, I'm told. Should benefit on a growing basis to the aging of the baby boomer population.
Recs
mikehux
(95.08)
Submitted: 10/29/2006 8:59:21 PM :
Start Price:
$43.81
LLY Score:
-8.05
people getting older
Recs
mhuheey
(60.67)
Submitted: 10/5/2006 7:24:44 AM :
Start Price:
$44.34
LLY Score:
-11.22
great pipeline
Recs
rudluv
(94.64)
Submitted: 9/23/2006 3:13:35 AM :
Start Price:
$43.18
LLY Score:
-11.24
Cymbalta will do better than expected
Recs
myinequities
(36.99)
Submitted: 9/15/2006 6:11:01 AM :
Start Price:
$42.52
LLY Score:
-9.19
Yes, I know Cramer thinks LLY is a great rebalancing play. By now, the whole world knows so who knows if this'll really happen. I hope so, but regardless, I'm holding LLY for the long-term. They do have a great pipeline and I view the oppty arguably better than a few others that have had a nice run. I really like AZN (which is up 30%+ this year) but don't know how many more legs it has. So, while I'm not selling my AZN yet, I'm buying into LLY for upside in 2007.
Recs
mikesweitzer
(< 20)
Submitted: 9/14/2006 3:22:30 PM :
Start Price:
$42.34
LLY Score:
+9.81
Won't move enough to matter
Recs
jeremyyma
(49.80)
Submitted: 9/13/2006 5:37:31 PM :
Start Price:
$42.59
LLY Score:
-10.10
drug pipe line
Recs
JohnyRay
(78.08)
Submitted: 9/10/2006 10:54:53 PM :
Start Price:
$42.26
LLY Score:
-11.16
Visionary company. Nice pipeline and will do great over the next 5 years.
Recs
golfwineski
(24.11)
Submitted: 9/8/2006 3:01:58 AM :
Start Price:
$38.64
LLY Score:
+1.87
Use to work there...anemic, in-bred culture...stock has done nothing in last 7 years, xyprexa off patent in 2010. Despite calls they have one of the best pipelines, stock sucks and is fairly if not over valued.
Recs
hossiergirl
(< 20)
Submitted: 8/25/2006 4:00:59 AM :
Start Price:
$42.28
LLY Score:
-11.44
Pharmaceuticals seems to be a choice with an aging population and Lilly seems poised with good possibilities in the pipeline
Recs
jeffini
(79.18)
Submitted: 8/24/2006 9:37:00 PM :
Start Price:
$42.28
LLY Score:
-11.44
solid source of growth and income.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 181 - 200 of 202 : « Previous 5 6 7 8 9 10 11 Next »